Radio and PodcastRadio and PodcastLive Radio & Podcasts
Zykadia for ALK Positive Lung Cancer: New Drug, New Hope artwork
Science & Medicine

Zykadia for ALK Positive Lung Cancer: New Drug, New Hope

GRACEcast by Howard (Jack) West, MD

Jul 13, 201407:22Science & Medicine

The doctors discuss the new FDA-approved drug for ALK positive lung cancer patients, Zykadia (ceritinib), including the dosage level, potential side effects and the ability of Zykadia to impact brain metastases.

Related Episodes

Continue listening to more episodes from GRACEcast.

Management of Rare Kidney Tumors

Jul 29, 2014 - 01:55

What puts you at risk for inherited kidney cancer? Dr. Nizar Tannir discusses the signs doctors look for...